Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity

Lauren K Dobbs1, Gregory P Mark

  • 1Department of Behavioral Neuroscience, Oregon Health & Sciences University, School of Medicine, 3181 Sam Jackson Park Rd., Portland, OR 97239, United States. dobbsl@ohsu.edu

Behavioural Brain Research
|September 28, 2011
PubMed

Insights

Laterodorsal tegmental (LDT) acetylcholine (ACh) influences methamphetamine (MA) effects on locomotion and brain chemistry. LDT-derived ACh is crucial for MA-induced locomotor activity and the cholinergic, but not dopaminergic, response to MA.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Methamphetamine (MA) elevates dopamine (DA) in the mesolimbic pathway and acetylcholine (ACh) in the ventral tegmental area (VTA).
  • The laterodorsal tegmental (LDT) and pedunculopontine tegmental (PPT) nuclei are primary sources of VTA cholinergic input.
  • The specific roles of LDT- and PPT-derived ACh in MA's effects on DA, ACh, and locomotion are not fully understood.

Purpose of the Study:

  • To investigate the contribution of LDT-derived ACh to MA-induced locomotor activation.
  • To determine the individual roles of LDT and PPT ACh in modulating MA-induced ACh and DA levels in the VTA and nucleus accumbens (NAc).

Main Methods:

  • Reversible inhibition of LDT neurons using intra-LDT microinjections of the M2 receptor agonist oxotremorine (OXO) in mice.
  • Assessment of locomotor activity following OXO administration before saline or MA injection.
  • In vivo microdialysis in the VTA and NAc to measure ACh and DA levels after intra-LDT or intra-PPT OXO administration.

Main Results:

  • High-dose OXO in the LDT significantly reduced both saline- and MA-induced locomotor activity.
  • Intra-LDT OXO dose-dependently attenuated the MA-induced increase in VTA ACh levels.
  • Neither intra-LDT nor intra-PPT OXO affected MA-induced DA levels in the NAc, and intra-PPT OXO did not alter ACh levels in the VTA.

Conclusions:

  • ACh originating from the LDT, but not the PPT, plays a significant role in locomotor behavior.
  • LDT-derived ACh is critical for the cholinergic, but not the dopaminergic, neurochemical response to systemic MA.
  • These findings highlight the specific involvement of LDT cholinergic pathways in mediating behavioral and neurochemical effects of MA.

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...